Health: De Stefano (L), 'Gene editing offers new strategies for treating neurological diseases'

Gene editing and messenger RNA modifications allow us to influence the mechanisms that regulate the production of certain proteins, responsible for dysfunctions that can lead to chronic diseases, such as amyotrophic lateral sclerosis (ALS) and some forms of dementia. In some cases, we can intervene using molecules we call antisense oligonucleotides, with the aim of modifying these mechanisms.

Nicola De Stefano, president-elect of SIN – the Italian Society of Neurology, explained this during the 56th Congress of the Italian Society of Neurology (SIN), scheduled for October 24–27, 2026 in Florence.

https://www.youtube.com/watch?v=oQb_QMBuKBE